KOD Kodiak Sciences Inc.
Healthcare$36.23-3.15%ClosedMarket Cap: $1.92B
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
19.99
P/S
0.00
EV/EBITDA
-8.81
DCF Value
$2.62
FCF Yield
-7.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-253.8%
ROA
-75.4%
ROIC
-87.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-59.8M | $-58.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-57.5M | $-56.7M | $— | — |
| FY null | $0.00 | NaN% | $-234.4M | $-230.0M | $— | — |
| Q3 null | $0.00 | NaN% | $-62.4M | $-61.5M | $— | — |
| Q2 null | $0.00 | NaN% | $-55.5M | $-54.3M | $— | — |
| Q1 null | $0.00 | NaN% | $-59.1M | $-57.5M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-46.2M | $-44.1M | $— | — |
| FY null | $0.00 | -Infinity% | $-186.8M | $-176.2M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-46.6M | $-43.9M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-48.0M | $-45.1M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-46.1M | $-43.0M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-63.4M | $-59.5M | $-1.13 | — |